Neoadjuvant ixabepilone/carboplatin/trastuzumab in HER2-positive locally advanced breast cancer: A Sarah Cannon Research Institute phase II trial.
J. D. Zubkus
No relevant relationships to disclose
D. B. Daniel
No relevant relationships to disclose
J. F. Eakle
No relevant relationships to disclose
R. G. Bechhold
No relevant relationships to disclose
M. Shastry
No relevant relationships to disclose
P. S. Tucker
No relevant relationships to disclose
H. A. Burris
No relevant relationships to disclose
J. D. Hainsworth
No relevant relationships to disclose
D. A. Yardley
No relevant relationships to disclose